Introduction
During development, cortical projection neurons are generated in the ventricular and subventricular zones (VZ/SVZ), 2 proliferative niches that surround the lateral ventricles. After exiting cell cycle, pyramidal neurons undergo radial migration toward the cortical plate (CP) to finally occupy their corresponding cortical layer. Proper migration of neurons is essential as it establishes the basis for the subsequent wiring of the cortical circuitry. Not surprisingly, brain organization abnormalities emerge as a consequence of disrupted neuronal migration, which can have devastating consequences on adult brain function, including mental retardation, cognitive disorders, and epilepsy. Double cortex syndrome or subcortical band heterotopia (SBH) is a type of migration disorder consisting in heterotopic accumulations of cortical neurons within the subcortical white matter (WM) (Valiente and Marín 2010; Barkovich et al. 2012) . SBH is believed to increase seizure susceptibility by causing focal hyperexcitability of cortical areas directly connected with the subcortical lesions (Shafi et al. 2015) .
Pyramidal neuron migration requires the adoption of different morphologies along their transition through the various cortical compartments (Noctor et al. 2004) . Actin filaments and microtubules control complementary aspects of neuronal migration. Overall, the actin cytoskeleton plays an essential role in cell polarization and leading process extension, while the microtubular network is fundamental for nucleokinesis. Nowadays, we know a number of genes encoding cytoskeletal or cytoskeleton-associated proteins, such as TUBA1A, Doublecortin (DCX) Lissencephaly-1 (LIS 1), and FilaminA, whose mutations underlie severe human malformations of cortical development (MCDs), including SBH, X-linked periventricular heterotopia (PH) and lissencephaly (Barkovich et al. 2012) . Additionally, Rho GTPases are crucial regulators of actin cytoskeleton dynamics (Heasman and Ridley 2008) and therefore, several members of this protein family play a pivotal role in neuronal migration (Govek et al. 2011; Azzarelli et al. 2014a) . Specifically, Rac1 and Cdc42 modulate different phases of cortical neuron migration in a cell-autonomous fashion (Konno et al. 2005) , while RhoA exerts a key non-cell autonomous contribution to pyramidal neuron migration, its expression being required in radial glial cells but not in migrating neurons (Cappello et al. 2012) . The inactivation of RhoA emerges as a critical requirement for the polarization of cortical projection neurons during migration, and different cell-autonomous and extrinsic factors converge in RhoA inhibition to promote migration (Hand et al. 2005; Nguyen et al. 2006; Pacary et al. 2011; Tang et al. 2014; Azzarelli et al. 2014b ). How promigratory extracellular signals modulate the intrinsic regulators responsible for neuronal migration is beginning to be understood. Semaphorins, by acting through PlexinB2 receptors, modulate RhoA activity to favor a promigratory cytoskeletal configuration (Azzarelli et al. 2014b ). Some G protein-coupled receptors (GPCRs), such as the GABA B receptor (Bony et al. 2013 ) and the serotonin 5-HT 6 receptor, also promote radial migration of pyramidal neurons, in the latter case in a ligand-independent manner (Jacobshagen et al. 2014 ). Other GPCRs have been associated with neuronal migration disorders, for example GPR56 with polymicrogyria, but their mechanism of action remains unknown (Piao et al. 2004 ).
The cannabinoid CB 1 receptor is a GPCR physiologically engaged by a family of lipid ligands, the endocannabinoids (eCBs), among which 2-arachidonoylglicerol (2-AG) and N-arachidonoylethanolamine (anandamide) are the best characterized. Besides its well-known neuromodulatory role mediating retrograde suppression of neuronal activity at adult synaptic terminals (Soltesz et al. 2015) , the CB 1 receptor plays several roles during CNS development. The CB 1 receptor is expressed in the developing cerebral cortex, where it controls the proliferation and phenotype of cortical neural precursor cells (Díaz-Alonso et al. 2014) , the specification of pyramidal neurons (Díaz-Alonso et al. 2012) , and axon guidance and synaptogenesis (Mulder et al. 2008; Vitalis et al. 2008; Keimpema et al. 2010; Argaw et al. 2011) . In addition, the CB 1 receptor regulates neuronal migration in the embryonic brain (Mulder et al. 2008) , and eCB signaling promotes migration of newborn neurons along the rostral migratory stream in the postnatal mouse brain (Oudin et al. 2011 ). However, the molecular mechanisms and pathophysiological implications of CB 1 receptor signaling-mediated regulation of pyramidal neuron migration remain unknown. Given that cannabis is the most widely used illicit drug during pregnancy (Jutras-Aswad et al. 2009 ), deciphering how its main molecular target-the CB 1 receptor-signals in the developing brain is critical for understanding the neurobiological processes potentially affected in the fetus upon cannabis consumption during pregnancy.
In this study, we performed transient siRNA-mediated CB 1 receptor knockdown in newborn pyramidal neurons to reveal the impact of developmentally restricted, short-term CB 1 receptor loss of function in their migration. We observed a migration arrest that led to profound and long-lasting alterations in cortical neuron positioning, including SBH. Consequently, seizure susceptibility was increased in adult mice. Biochemical and cellular analyses showed that loss of CB 1 receptor function led to an abnormal RhoA protein accumulation in newborn pyramidal neurons, thereby disrupting the morphology of migrating cells. Remarkably, migration deficits elicited by loss of CB 1 receptor function were fully rescued by RhoA knockdown. Collectively, our findings pave the way toward a better understanding of the physiological role of eCB signaling in brain development, and provide relevant molecular mechanistic insights into human MCDs caused by altered neuronal migration. 
Materials and Methods

Materials
Immunofluorescence and Confocal Microscopy
Cell proliferation was determined after intraperitoneal bromodeoxyuridine (BrdU) injection (50 μg/g body weight) of pregnant females at E14.5. Coronal embryonic and postnatal brain slices (14 and 30 μm thick, respectively) were processed as previously described (Palazuelos et al. 2009; Díaz-Alonso et al. 2012) .
Immunofluorescence was performed, after blockade with 5% goat serum, by overnight incubation at 4°C with the indicated primary antibodies (see Supplementary Information).
In Situ Hybridization
Coronal sections (20 μm) of E16.5 and E17.5 embryonic mouse brains were obtained and processed for ISH as described (Díaz-Alonso et al. 2012) using antisense and sense CB 1 riboprobes (Marsicano and Lutz 1999) . Further details are provided in Supplementary Information.
In Utero Electroporation
The indicated siRNAs or expression constructs (see Supplementary Information) were electroporated at a final concentration of 10 μM or 1 μg/μl, respectively, into the lateral ventricle of E13.5 or E14.5 embryos as described previously (Pacary et al. 2011) . All electroporations shown include a constitutive GFP overexpression plasmid (pCAG-GFP) to allow proper visualization.
Explant Migration Assays
Cortical explants were prepared from E14.5 embryonic forebrain slices. Briefly, small cortical fragments of about 400 µm were dissected with scalpel and incubated for 1 h in Minimum Essential Medium Eagle EMEM (Lonza) containing 10% FBS, 1% glucose at 37°C in 5% CO 2 . COS7 cell aggregates transfected with the indicated expression vectors (see Supplementary  Information) were prepared by diluting a pellet of transfected cells with Matrigel (BD) in a 1:1 proportion. After jellification, cell aggregates were cut with a scalpel in small cubes of 600 µm. Subsequently, cortical explants were placed in a Matrigel 3-dimensional matrix facing the corresponding COS7-transfected cell aggregates. Cocultures were maintained in Neurobasal culture medium (Gibco), supplemented with N2 (Millipore) and B-27 (Invitrogen) for 72 h, and then fixed. Cell migration from the explants was analyzed in 4 quadrants by quantification of cell nuclei counterstained with DAPI, and the proximal/distal ratio with respect to the corresponding cell aggregate was calculated.
RhoA Activity Measurement
Dorsal telencephali from E17.5 Nex-CB 1 −/− and CB 1 f/f littermates were carefully dissected and directly processed for active RhoA quantification with the G-LISA kit (Cytoskeleton Inc.), following the manufacturer's instructions.
Susceptibility to PTZ
Mice were placed in Plexiglas cages and monitored by an experimenter blinded to their treatment and genotype. PTZ (Sigma-Aldrich) was dissolved in 0.9% saline and administered intraperitoneally to mice at P60 at a concentration of 22.5 mg/ kg every 10 min until generalized seizures occurred. Seizure severity was monitored as described (Manent et al. 2009; de Salas-Quiroga et al. 2015) . Mice placed in Plexiglas cages were injected with the PTZ-containing solution every 10 min, with consecutive injections of PTZ until generalized seizures occurred. This was considered the end of the experiment. All the procedure was video-recorded and analyzed later by an experimenter blinded to the experimental groups, who determined the precise moment of generalized seizure onset. There was no statistically significant difference in weight or sex ratio between the different groups of mice.
Statistical Analysis
Results shown represent the means ± SEM, and the number of independent experiments or biological samples is indicated in every case. Statistical analyses were performed by StudentNewman-Keuls post hoc test. Experimental procedures are further described in Supplementary Methods. That section includes a detailed description of animal procedures, antibodies employed for immunofluorescence and confocal microscopy, ISH, sequences of siRNAs and constructs employed in in utero electroporation (IUE) and explant migration assays, adherent cortical progenitor cell culture, quantitative PCR, immunoblot assays and data analysis and statistics.
Results
Acute Cannabinoid CB 1 Receptor Knockdown Blocks Radial Migration
To evaluate the role of the CB 1 receptor in neuronal migration, we initially confirmed CB 1 receptor expression in the developing cortex at E17.5. CB 1 receptor mRNA and protein show a gradient with increased levels in postmitotic compartments of the developing cortex, that is, the intermediate zone (IZ) and the CP ( Supplementary Fig. 1A-C) , suggesting that CB 1 receptor expression is upregulated in newborn pyramidal neurons after cell cycle exit and radial migration initiation (Mulder et al. 2008; Díaz-Alonso et al. 2014) . We also explored the presence of CB 1 receptor in developing pyramidal neurons by combining CB 1 ISH with Satb2 immunofluorescence ( Supplementary Fig. 1A , right panel). Confocal analysis further confirmed CB 1 receptor protein expression in immature Satb2
+ pyramidal neurons in E17.5 embryonic cortices, a large proportion of which are undergoing radial migration at this developmental stage ( Supplementary Fig. 1C ). During development, the CB 1 protein is enriched in axons of immature pyramidal neurons ( Supplementary Fig. 1C ) (Berrendero et al. 1999; Mulder et al. 2008 ), making extremely difficult to estimate the contribution of somatic CB 1 immunostaining in migrating neurons to the overall staining. Thus, to recapitulate CB 1 receptor expression in migrating pyramidal neurons, we used ISH of CB 1 receptor transcripts in GFP-positive cells in E16.5 embryonic cortices subjected to IUE at E14.5 ( Supplementary Fig. 1B ). As developing GABAergic interneurons also express CB 1 receptor (Berghuis et al. 2007; Morozov et al. 2009) , to unequivocally assess the presence of CB 1 receptor in pyramidal neurons we took advantage of the Dlx5/6-driven forebrain GABAergic neuron-selective CB 1 -deficient mice ). Thus, in Dlx5/6-CB 1 −/− embryonic cortices, CB 1 immunostaining was hardly distinguishable from their CB 1 f/f littermates ( Supplementary Fig. 1D ), while in the developing hippocampus a clear reduction of CB 1 receptor expression was evident. Overall, these results confirm the expression of CB 1 in radially migrating pyramidal neurons, in addition to its presence in developing interneurons (Berghuis et al. 2007; Morozov et al. 2009 ).
We then assessed the cell-autonomous role of CB 1 receptor signaling in pyramidal neuron migration during cortical development. To this end, we acutely knocked down the CB 1 receptor in radially migrating neurons at E14.5 by IUE of a pool of siRNAs directed against 4 sequences of the CB 1 receptor mRNA (hereafter CB 1 siRNA) together with a GFP expression construct, and subsequently analyzed the distribution of radially migrating cells at different time points. In our hands, transfection of cortical cells with this siRNA pool reduces CB 1 receptor expression by 50% (Díaz-Alonso et al. 2014) . CB 1 receptor knockdown significantly impaired newborn pyramidal cell migration ( Fig. 1A-C) . Remarkably, after either 2 days (Supplementary Fig.  2A ,B) or 3 days (Fig. 1A ,B) in utero we observed a reduced colonization of the CP by CB 1 -knockdown cells that, instead, appeared stacked in the IZ and the VZ/SVZ. Moreover, when we restricted our analyses to the cells that had reached the CP we also found a significant delay in CB 1 siRNA-electroporated cells, that were less abundant in upper cortical layers of the cortex, to which E14.5-born neurons are committed to migrate (Greig et al. 2013) (Fig. 1C) . We confirmed that acute CB 1 receptor silencing impairs radial migration by using additional strategies: both a CB 1 short-hairpin RNA (shRNA, not shown) and Cre recombinase electroporation of CB 1 f/f embryos ( Supplementary   Fig. 2C ,D) impaired migration of cortical projection neurons at very similar extents than siRNA-mediated CB 1 knockdown.
To invade the CP, migrating neurons must undergo a morphological switch from their characteristic multipolar shape, adopted to explore the SVZ and IZ environment, to a bipolar morphology, which enables their radial glial-aided migration in the CP (Heng et al. 2008; Pacary et al. 2011) . siRNA-mediated CB 1 knockdown increased the number of primary neurites in cultured E14.5 cortical neurons (Supplementary Fig. 2E-G) . Hence, we analyzed whether silencing of CB 1 receptors affects the morphology of migrating neurons in vivo. We quantified the number of GFP + cells with >2 primary processes in the CP of control siRNA and CB 1 siRNA-transfected brains, and found a 2-fold increase in the proportion of cells with this aberrant morphology in CB 1 siRNA-electroporated cortices ( Fig. 1D ,E), thereby indicating that radial migration blockade occurs concurrently with an impairment of the multipolar to bipolar transition.
Transient CB 1 Receptor Knockdown Long-Lastingly Impairs Pyramidal Neuron Migration and Generates SBH
To assess whether CB 1 -knockdown cells suffer from a transient delay in their radial migration and finally reach the appropriate cortical layer if given enough time, as is the case following the silencing of other cell migration regulators (Creppe et al. 2009 ; Graphs represent mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Scale bars: (A) 100 μm; (D) 10 μm. Manent et al. 2009 ), we extended our IUE experiments until early postnatal life (P2 and P10), when the siRNA is no longer active. In P2 brains, the migration arrest observed upon CB 1 expression manipulation was still present ( Fig. 2A,B) , thus confirming that temporally restricted CB 1 receptor loss of function compromises radial migration of newborn neurons in the developing cortex. In P10 brains, we observed a greater proportion of GFP + cells in the upper layers of CB 1 siRNA- (Fig. 2C,D) . siRNA-electroporated mice that develop until young adults (P60) were assessed for the definitive positioning of transfected cells. Strikingly, we still found subcortical accumulations of GFP + neurons in 6 out of 9 CB 1 siRNAelectroporated brains (Fig. 2G-I ).
We next determined the identity of GFP + CB 1 -knockdown cells at postnatal stages. Cells found in deep cortical layers of CB 1 siRNA-transfected brains at P10 were immunoreactive for the callosal projection neuron specification marker Satb2 (Alcamo et al. 2008) (Fig. 2E,F) . We found that virtually all GFP + cells in the subcortical heterotopias at P60 were also immunopositive for Satb2 (Fig. 2G -G""), even though the expression of this transcriptional regulator in the telencephalon is normally confined to the cerebral cortex (Alcamo et al. 2008 ). This observation indicates that migration-arrested cells retain their corresponding callosal specification program even in ectopic locations. We then asked about the nature of the ectopic neuronal accumulations found in CB 1 siRNA-transfected brains. SBH can be distinguished from PH because neuronal accumulations are surrounded by a glial capsule in SBH but not in PH. Hence, we stained samples from CB 1 siRNA-electroporated P60 brains for the astrocytic marker GFAP and confirmed that the neuronal accumulations correspond to the SBH type (Fig. 2H ).
We then explored whether the observed CB 1 receptordependent promotion of radial migration was unique of E14.5-born cells. To this end, we performed IUE at E13.5 and conducted analyses 3 days later ( Supplementary Fig. 2H,I ). Similarly to our previous manipulations at E14.5, when targeting E13.5-born cells an overall delay in GFP + cell migration was observed in CB 1 -knockdown brains after 3 days in utero. Furthermore, delayed radial migration was still present at P2 in CB 1 f/f neurons electroporated at E13.5 with a Cre recombinase expression vector ( Supplementary Fig. 2C,D) .
The CB 1 Receptor Promotes Radial Migration of Postmitotic Pyramidal Neurons
The CB 1 receptor plays an active role in the regulation of cortical progenitor cell proliferation and identity (Mulder et al. 2008; Díaz-Alonso et al. 2014) . Hence, we determined whether the observed CB 1 receptor-dependent promotion of pyramidal neuron migration involves CB 1 receptors located on cortical progenitor cells. To test this possibility, we electroporated a Cre recombinase-encoding construct driven by the postmitotic neuron-specific promoter Dcx in E14.5 CB 1 f/f embryos, and analyzed the position of targeted cells at E17.5 ( Fig. 3A-C) . A clear migration defect was evident upon CB 1 receptor ablation exclusively in postmitotic neurons. Importantly, this manipulation also affected the morphology of migrating GFP + cells (Fig. 3D,E ).
Moreover, we tested whether postmitotic CB 1 receptor ablation results in a transient or permanent migration impairment by allowing the electroporated embryos to develop until P2. Although many of the electroporated cells were found in the heterotopic GFP + cell accumulations were consistently found in subcortical areas (asterisk). n = at least 3 different embryos from different litters per condition.
Graphs represent mean ± SEM. Scale bars: (A, F) 100 μm; (D) 10 μm. *P < 0.05; **P < 0.01; ***P < 0.001.
upper cortical layers at this stage, we consistently found accumulations of Dcx-Cre + cells ectopically located in the WM (Fig. 3F ). These observations demonstrate that CB 1 receptor signaling promotes radial migration in postmitotic neurons independently of the pyramidal precursor cell pool. We sought for additional support to the postmitotic nature of the CB 1 receptor promigratory role by analyzing the migration of postmitotic neurons in CB 1 −/− embryos. Constitutively null mutation of CB 1 receptors has been shown to affect several aspects of pyramidal neuron development (Mulder et al. 2008) , although its precise impact on radial migration remains unclear. Thus, we performed birthdate labeling experiments in CB 1 -knockout embryos and control littermates by administering BrdU at E14.5 followed by double immunofluorescence for BrdU and Ki67 at E16.5 in order to discard cells that were still proliferating. BrdU + Ki67 − cells, that is, the cells that had exited cell cycle between E14.5 and E16.5, were significantly delayed in their radial migration in CB 1 −/− embryos when compared to WT littermates ( Supplementary Fig. 3A,B) . As the CB 1 receptor is known to trigger prosurvival mechanisms in neurons (Galve-Roperh et al. 2008), we assessed whether its knockdown interferes with neuronal migration by affecting cell viability. Hence, we analyzed the apoptosis marker cleaved caspase-3 in cortices subjected to IUE with the CB 1 siRNA. We did not find significant differences in apoptotic cells in the developing cortex of CB 1 siRNA-electroporated and control siRNA-electroporated cortices ( Supplementary Fig. 3C ). Likewise, no differences were observed by TUNEL staining in CB 1 siRNA-electroporated versus control cortices ( Supplementary  Fig. 3D ), thus ruling out a contribution of neuronal survival in the promigratory effect of the CB 1 receptor.
The eCBs 2-AG and Anandamide Act as Chemoattractant Cues for Newborn Pyramidal Neurons
To better understand the mechanism of CB 1 receptor-driven neuronal migration, we first investigated the ability of endogenous cannabinoid ligands to modulate pyramidal neuron migration. We prepared E14.5 dorsal telencephalic explants and exposed them to a confined source of eCBs. Diacylglycerol lipase alpha (DAGLα) is the key enzyme involved in 2-AG synthesis, and mice lacking this enzyme show impaired eCBmediated neuromodulation and compromised adult neurogenesis (Gao et al. 2010) . Neurons arising from cortical explants showed a marked preference to migrate toward DAGLα-overexpressing COS7 cells when compared with control, GFPtransfected cells (Fig. 4A,B) . Importantly, this effect was blocked by the CB 1 receptor antagonist SR141716. Anandamide biosynthesis is mainly achieved through the action of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). Likewise, the migration of neurons from cortical explants was favored toward COS7 cells overexpressing NAPE-PLD, this effect being also blocked by SR141716. Thus, both eCBs promote pyramidal neuron migration by acting through CB 1 receptors.
The aforementioned observations could be explained by two alternative mechanisms: eCBs might either promote neuronal motility and/or instruct the directionality of neuronal migration. To dissect these 2 processes, we overexpressed DAGLα in utero at E14.5 to disrupt the gradient of eCBs, and analyzed neuronal migration at E17.5. DAGLα-overexpressing cells showed a mild though significant migration delay compared with GFP-electroporated cells, thus suggesting that blurring the cortical eCB gradient misleads neuronal migration (Fig. 4B) . We then evaluated the non-cell autonomous consequences of disturbing the cortical gradient of 2-AG on the subsequent waves of migrating neurons. Thus, we injected BrdU 12 h after DAGLα electroporation to label proliferating cells, and then tracked their migration at E17.5. BrdU-labeled cells accumulated aberrantly in the VZ of DAGLα-electroporated brains, where DAGLα-overexpressing cells were most abundant ( Fig. 4C-E) , thus indicating that abnormally high levels of 2-AG in the apical side of the cortex prevent proper newborn neuron migration. These findings suggest that eCBs may act as spatially regulated cues for the adequate migration of pyramidal neurons in the developing cortex.
CB 1 Receptor Signaling Promotes RhoA Degradation in Migrating Pyramidal Neurons
Several signaling pathways involved in the regulation of neuronal migration converge in the modulation of the activity of the small GTPase protein RhoA (Cappello et al. 2012; Pacary et al. 2013; Azzarelli et al. 2014b) . Given the morphological alterations found in CB 1 -deficient migrating cells described above, and the previous evidence suggesting a functional link between CB 1 receptor signaling and RhoA activity in both neuronal (Berghuis et al. 2007 ) and non-neural (Nithipatikom et al. 2012; Mai et al. 2015 ) cells, we hypothesized that the promigratory effect of the CB 1 receptor in newborn pyramidal cells relies on the modulation of this pathway. To investigate whether CB 1 receptor signaling regulates RhoA activity in vivo, we measured the amount of GTP-bound RhoA in cortical tissue extracts from E17.5 embryos, when a large proportion of neurons are undergoing migration. We employed dorsal telencephalic glutamatergic neuron-specific CB 1 receptor knockouts (Nex-CB 1 −/− ) to determine the regulation of RhoA activity by CB 1 signaling specifically in postmitotic cortical pyramidal neurons (Díaz-Alonso et al. 2012). We found that active RhoA levels were increased by 2-fold in E17.5 Nex-CB 1 −/− cortices compared with their CB 1 f/f littermates ( Fig. 5A ), suggesting that CB 1 receptor signaling dampens RhoA activity in migrating pyramidal neurons. This observation indicates that in Nex-CB 1 −/− cortical tissue either the active fraction of RhoA is increased and/or there is an accumulation of total RhoA protein. Hence, we examined total RhoA protein levels by western blot and also found a 2-fold increase in Nex-CB 1 −/− tissue extracts compared with their CB 1 f/f littermates ( Fig. 5B) , thus indicating that CB 1 inactivation in postmitotic pyramidal neurons leads to an accumulation of RhoA protein rather than to an increase in the active fraction of RhoA. We subsequently analyzed RhoA expression in those samples by qPCR and found no significant difference ( Supplementary  Fig. 4A ), suggesting that CB 1 receptor signaling likely controls RhoA at a post-translational level rather than by regulating its gene transcription. The mRNA expression levels of other Rhofamily members involved in neuronal migration, RhoB, Rac1, and Cdc42, were not affected either by CB 1 receptor ablation ( Supplementary Fig. 4A ).
To determine whether acute CB 1 receptor knockdown strategy also modifies RhoA protein levels, we performed ex vivo electroporation of CB 1 siRNA or control siRNA together with GFP into E14.5-mouse embryonic dorsal telencephalon, and maintained dissociated cortical cells for 4 days in vitro (DIV). In agreement with knockout mice-derived tissue, RhoA immunoreactivity was increased in CB 1 siRNA-transfected compared with control siRNA-transfected GFP + cells (Fig. 5C,D) .
It has been recently reported that RhoA expression in pyramidal neurons is largely dispensable for their migration, and that its overactivation results in radial migration arrest . n = at least 3 different embryos from different litters per condition. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01 (Student's ttest). ***P < 0.001 versus GFP/Vehicle-treated slices of GFP-electroporated embryos; # P < 0.05; ### P < 0.001 versus the corresponding vehicle-treated explants. Scale bars:
(A) 100 μm; inset 500 μm; (C) 100 μm. (Pacary et al. 2011; Cappello et al. 2012) . This is consistent with the expression pattern of RhoA in the developing cortex, which shows a clear downregulation of RhoA in migrating neurons compared with cortical progenitors (Azzarelli et al. 2014a ). We designed an experimental approach aimed at recapitulating the cellular context of migrating pyramidal neurons to study how CB 1 signaling affects RhoA levels. Thus, we obtained adherent cortical progenitor cell (CPC) cultures, which can be differentiated into cortical neurons by changing the medium and withdrawing growth factors (see Supplementary Methods). antagonist SR (1 μΜ) and with the proteasome inhibitor MG132 (10 μΜ). (F) RhoA protein levels were determined by western blot in cortical samples from E17.5 embryos exposed to the CB1 agonist WIN55,212-2 (5 mg/kg) or its vehicle for 6 h. n = at least 3 different embryos per genotype or treatment. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01; # P < 0.05 versus HU-210-treated cells. Scale bar: 25 μm.
Characterization of CPC cultures ( Supplementary Fig. 5A-E) revealed their appropriateness to model the cellular context of a migrating cortical neuron. As expected, neuronal differentiation reduced nestin and Pax6 expression, while increasing the expression of the neuronal marker Tuj1 and the CB 1 receptor. RhoA expression also decreased with differentiation, mirroring the abrupt downregulation that occurs during pyramidal neuron maturation in vivo. To evaluate whether CB 1 receptor manipulation during this process affects RhoA protein levels, we stimulated CB 1 signaling in differentiating CPCs with the cannabinoid agonist HU-210 and observed that CB 1 receptor activation led to a decrease in total RhoA protein levels compared with vehicle-treated CPCs (Fig. 5E) . Noteworthy, HU-210-induced reduction of RhoA levels was prevented by SR141716. Differentiating CPCs were also co-incubated with HU-210 and the proteasome inhibitor MG132, and HU-210-induced regulation of RhoA levels was abolished (Fig. 5E ). These results indicate that CB 1 receptor signaling promotes proteasomal degradation of RhoA in newborn pyramidal neurons. We also evaluated whether pharmacological stimulation of the CB 1 receptor affects RhoA protein levels in developing cortical neurons in vivo. We administered the cannabinoid agonist WIN55,212-2 or its vehicle to pregnant females in gestational day 17 and embryos were collected 6 h later. Cannabinoid administration resulted in the reduction of RhoA protein levels (0.55 ± 0.08 vs. vehicle-treated RhoA levels) in embryonic cortical extracts (Fig. 5F) , without affecting the expression of RhoA, RhoB, Cdc42, or Rac1 (Supplementary Fig. 4B ). Considering that RhoB is highly expressed during cortical development, its homology, and function redundancy with RhoA, we also analyzed RhoB protein levels upon CB 1 receptor genetic and pharmacological manipulation. RhoB levels were increased in Nex-CB 1 -deficient mice cortical extracts, while WIN55,212-2 administration in vivo and HU-210 treatment of CPCs decreased RhoB levels ( Supplementary Fig. 6 ).
RhoA Downregulation Is Sufficient to Rescue CB 1 Receptor Knockdown-Induced Migration Arrest
The aforementioned findings indicate that CB 1 receptor silencing leads to RhoA protein accumulation in newborn pyramidal neurons. To test whether this effect underlies the migration impairment in CB 1 siRNA-electroporated cells, we coelectroporated a RhoA-directed shRNA together with the CB 1 siRNA. The efficacy of the RhoA shRNA to decrease RhoA expression has previously been demonstrated (Pacary et al. 2011) . As shown in Figure 6 , knocking-down RhoA fully rescued CB 1 silencing-induced migration arrest, and restored both the distribution of GFP + cells along the different cortical compartments (VZ/SVZ, IZ, and CP; Fig. 6B ) and the adequate positioning of the cells within the CP (Fig. 6C ). This observation provides evidence for the notion that RhoA accumulation upon CB 1 knockdown underlies the impairment of neuronal migration. Cofilin is a downstream effector of RhoA that promotes actin filament disassembly. Since F-actin depolymerization is required for neuronal migration as it allows the continuous dynamic recycling of actin cytoskeleton, we tested the ability of a nonphosphorylatable form of cofilin (cofilin S3A , Pacary et al. 2011) , which constitutively depolymerizes F-actin to rescue CB 1 receptor knockdown-evoked migration arrest. Expression of cofilin S3A rescued the siCB 1 -induced cell migration blockade as quantified by IUE experiments from E14 to E17 (Fig. 6A-C ). These and a GFP expression plasmid at E14.5 and analyzed 3 days later, at E17.5. Representative images are shown for the different conditions (A). GFP + cell distribution in the indicated developing cortical areas and within the CP was quantified (B, C). n = at least 3 different embryos from different litters per condition. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 versus siRNA control-electroporated brains; # P < 0.05; ## P < 0.01; ### P < 0.001 versus CB 1 siRNA-electroporated brains.
Scale bar: 100 μm.
findings indicate that RhoA accumulation in CB 1 -deficient cells compromises neuronal migration by altering actin cytoskeleton dynamics.
Neuronal Migration Arrest Induced by CB 1 Receptor Knockdown Increases Seizure Susceptibility in Adulthood
We next examined whether the rescue of radial migration by RhoA downregulation results in a correct neuronal positioning in the adult cerebral cortex. Electroporated embryos that developed until P60 were analyzed for the distribution of GFP + cells.
We found that the majority of CB 1 siRNA-electroporated brains showed SBH, while normal neuronal lamination and SBH were absent in brains co-electroporated with the RhoA shRNA (Fig. 7A) . Taken together, these findings demonstrate that preventing RhoA accumulation rescues the migration defects caused by CB 1 receptor silencing. Similarly to human MCDs, experimentally induced ectopic accumulations of cortical neurons are aberrantly wired to the cortical circuitry, thus leading to an overall increased susceptibility to seizures (Manent et al. 2009; Feliciano et al. 2011) . We studied whether migration deficits caused by in utero CB 1 receptor knockdown sensitize the offspring to seizures induced by the convulsant pentylenetetrazol (PTZ). We administered subconvulsive doses of PTZ intraperitoneally every 10 min to young adult (P60) mice, and measured the latency and cumulative dose of PTZ necessary for generalized seizures to occur. PTZ susceptibility was significantly increased in CB 1 siRNA-electroporated mice, as shown by the reduced threshold for generalized seizures. Noteworthy, the rescue of CB 1 siRNA-induced neuronal migration arrest achieved by shRhoA co-electroporation also prevented the increased seizure susceptibility (Fig. 7B,C) . RhoA knockdown alone did not significantly alter PTZ susceptibility. These observations indicate that developmental alterations generated by transient CB 1 receptor silencing in migrating pyramidal neurons decrease seizure threshold in adult offspring, and that the rescue of neuronal migration induced by simultaneous RhoA downregulation normalizes seizure susceptibility.
Discussion
Overall, this study reveals an unprecedented pivotal role of the cannabinoid CB 1 receptor signaling in the adequate migration and positioning of cortical pyramidal neurons, which dysfunction can trigger profound long-lasting alterations in brain function. It has been long assumed that adult CB 1 -deficient mice have increased seizure susceptibility owing to the loss of eCBdependent retrograde suppression of glutamate release from excitatory terminals (Katona and Freund 2008; Soltesz et al. 2015) . Of note, our study adds to this classical view by demonstrating that developmentally restricted loss of CB 1 receptor function also increases seizure susceptibility, likely by causing aberrant positioning of cortical neurons, thus conceivably affecting their wiring and sensitizing the resulting circuitry to epileptogenesis. Neuronal migration is largely dependent on the dynamic regulation of the cytoskeleton (Valiente and Marín 2010) . Actin cytoskeleton remodeling plays a fundamental role in this process, and the control of RhoA activity is a common feature of different promigratory pathways (Hand et al. 2005; Nguyen et al. 2006; Pacary et al. 2011; Tang et al. 2014; Azzarelli et al. 2014b ). The expression pattern of RhoA in the developing cortex, with high abundance in the VZ/SVZ and very low-if anylevels in the IZ and CP (Azzarelli et al. 2014a) , suggests that this protein is dispensable for pyramidal neuron migration, as siRNA/shControl condition is indicated (asterisk). (B, C) P60 mice subjected to IUE at E14.5 with CB1 or control siRNAs combined with RhoA or control shRNAs as above were injected i.p. with PTZ (22.5 mg/kg) every 10 min until generalized seizures occurred. The mean latency to the occurrence of generalized seizures is represented (B) and the cumulative PTZ dose necessary for the onset of generalized seizures was calculated (C). n = 10-14 mice per group. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01 versus siRNA control-electroporated mice; # P < 0.05; ## P < 0.01; versus CB1 siRNA-electroporated brains. demonstrated in a recent report (Cappello et al. 2012) . RhoA ubiquitination and degradation plays an important role in the regulation of neuronal cell morphology (Bryan et al. 2005; Tian et al. 2011 ) and affects cancer cell migration (Nethe and Hordijk 2010) . However, to the best of our knowledge, this is the first study that identifies a specific role of the proteasomal degradation of RhoA in the promotion of neuronal migration. Our findings are in agreement with the involvement of the small GTPase Rac1 degradation in cancer cell migration (Oberoi et al., 2012) . Taking into account the complementary expression pattern of both the CB 1 receptor and RhoA in the developing cortex, it is conceivable that CB 1 -mediated RhoA degradation ensures a complete clearance of the remaining RhoA protein in newborn neurons to allow their migration. Our results are also in line with previous findings supporting that the actin cytoskeleton is a major target of CB 1 signaling in developing neurons (Berghuis et al. 2007; Oudin et al. 2011; Roland et al. 2014; Njoo et al. 2015) . In addition, CB 1 receptor activation can reduce RhoB protein levels ( Supplementary Fig. 6 ), and therefore we cannot exclude a potential contribution of this related GTPase in CB 1 receptor-dependent neuronal migration. We found that the migration defects caused by CB 1 receptor silencing affect more a subset of the targeted GFP + cells. This might be related to the unequal knockdown efficacy among targeted cells and/or to the heterogeneity of a neuronal population in their capacity to compensate the loss of a given promigratory mechanism. Similarly, in humans, MCDs frequently affect only relatively small neuronal populations, even when caused by germline mutations (Lim and Crino 2013) . Interestingly, a recent study supports that the migration deficits caused by Dcx shRNA are due to off-target effects of such manipulation onto endogenous miRNAs (Baek et al. 2014 ). In line with this notion, the specificity of our CB 1 receptor genetic knockdown strategy and its consequences on radial migration blockade are validated by the comparable phenotypes observed when using CB 1 siRNA, CB 1 shRNA, and Cre-mediated ablation of the CB 1 receptor in CB 1 f/f mice. Noteworthy, the severe migration defects observed upon acute CB 1 receptor knockdown are notably subtler upon constitutive CB 1 receptor loss ( Supplementary Fig. 3A,B) . This is most likely due to compensatory mechanisms occurring in germline or lineage-specific knockout mice, as also occurs for other migration regulatory proteins such as Dcx (Bai et al. 2003) , amyloid precursor protein (Young-Pearse et al. 2007) , and EF-hand domain-containing protein 1 (de Nijs et al. 2009 ). A wide variety of neurodevelopmental diseases are caused by the disruption of neuronal migration. Understanding the biological mechanisms responsible for a finely tuned corticogenesis emerges as a key requisite for the elaboration of rational therapeutic strategies for the consequences of MCDs, including epileptogenesis and neuropsychiatric disorders. Noteworthy, a genetic origin has been identified for some human diseases caused by neuronal migration alterations, and the genes identified in such diseases correspond, in most cases, to cytoskeletal or cytoskeleton-regulatory proteins (Lim and Crino 2013) . Therefore, the implications of the malfunctioning of the eCB system in the origin of neurodevelopmental diseases caused by cell migration defects are exciting perspectives for future research. Of note, evidences in the literature associate gene alterations (i.e., copy number variations) and gene polymorphisms of some of the eCB system elements CNR1, DAGLA, NAPEPLD, ABHD12, or CNRIP1, with the occurrence of human diseases, such as autism spectrum disorders, intellectual disability, or the polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and cataract syndrome named as PHARC (Fiskerstrand et al. 2010; Blankman et al. 2013; Bragin et al. 2014) . Particularly, the CB 1 receptor encoding CNR1 gene has even put forward as a strong autism-related candidate gene, given the increased status of de novo mutations in this gene in samples from a cohort of 2588 autistic patients (Girirajan et al. 2013) or the strikingly high probability of CNR1 haploinsufficiency (Huang et al. 2010) . In agreement with these indications, CB 1 receptor signaling regulates the neuronal identity transcriptional factor axis Ctip2-Satb2 (Díaz-Alonso et al. 2012 ) that together with Tbr1 is responsible for neuronal connectivity deficits that associate with mental retardation and autism (Carpentier et al. 2013; Deriziotis et al. 2014; Huang et al. 2014) .
Alterations of multiple cellular mechanisms frequently converge in the pathogenesis of MCDs, and an unbalanced activity of CB 1 receptor signaling can affect cortical development by interfering with several processes in addition to neuronal migration (Díaz-Alonso et al. 2012 ). While SBH is most frequently originated from abnormal neuronal migration, some neocortical heterotopias are associated with ectopic progenitor cell divisions (Kielar et al. 2014) . CB 1 receptor signaling controls the activity of the phosphatidylinositol-3-kinase/mammalian target of rapamycin complex 1 pathway, both in neuronal precursors (Díaz-Alonso et al. 2014 ) and in mature neurons (Puighermanal et al. 2009) , and the deregulation of this signaling route is at the origin of some focal MCDs, in particular tuberous sclerosis, type 2 focal cortical dysplasia, and megalencephaly (Lim and Crino 2013) .
Beyond genetic alterations in elements of the cannabinoid signaling machinery, environmental insults can affect CB 1 receptor-dependent neuronal migration. In particular, prenatal exposure to the cannabinoids present in marijuana has been shown to affect fetal development in both mice and humans (Hurd et al. 2005; Jutras-Aswad et al. 2009; Tortoriello et al. 2014) . Although detrimental consequences in executive function have been reported in studies following children from mothers that smoked marijuana (Fried 2002) , the neurobiological substrate of these changes remains unknown. Altered CB 1 receptor signaling induced by long half-life phytocannabinoids may eventually interfere with neuronal migration, as previously shown for synthetic cannabinoids (Saez et al. 2014) . Likewise, gestational cannabinoid exposure may disturb cortical laminarization and cause changes in social behavior and cognition (Díaz-Alonso et al. 2012; Carpentier et al. 2013; de Salas-Quiroga et al. 2015) . Cannabinoids have a great potential as medicines owing to the broad distribution of their receptor targets throughout the body, together with their high safety and fair tolerability (Pertwee 2012) . In particular, cannabidiol, the most relevant nonpsychoactive phytocannabinoid, has recently received a huge attention as a promising pharmacologic tool for the management of pediatric epilepsies such as the Dravet and Gaston-Leroux syndromes (Devinsky et al. 2014) . However, as our study and other pieces of evidence support (Maccarrone et al. 2014) , cannabis intake, for both therapeutic and recreational use, must be exquisitely controlled if not absolutely discouraged during pregnancy in order to avoid interferences with the crucial role played by the CB 1 receptor during brain development.
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